Funding Opportunity PA-19-023 from the NIH Guide for Grants and Contracts. The purpose of the Funding Opportunity announcement is to encourage grant applications from the scientific community that develop and test tools to address symptoms in caregivers. The key to this announcement is the focus on the caregiver, regardless of patient symptoms or conditions. Research is needed to enhance symptom recognition and assessment in caregivers, and to promote technological strategies to alleviate distress in caregiver symptoms. These studies are needed to advance the science related to caregiver experience of symptoms, caregiving contexts that promote these symptoms, and viable tools to address the symptoms experienced by caregivers.

Funding Opportunity PA-19-024 from the NIH Guide for Grants and Contracts. The purpose of the Funding Opportunity announcement is to encourage grant applications from the scientific community that develop and test tools to address symptoms in caregivers. The key to this announcement is the focus on the caregiver, regardless of patient symptoms or conditions. Research is needed to enhance symptom recognition and assessment in caregivers, and to promote technological strategies to alleviate distress in caregiver symptoms. These studies are needed to advance the science related to caregiver experience of symptoms, caregiving contexts that promote these symptoms, and viable tools to address the symptoms experienced by caregivers.

Negotiable: Paramount Recruitment: Data Scientist Bioinformatics Data Science, Omics, Bioinformatics, Pharmaceutical Competitive salary, generous relocation package, great work-life balance! A fantastic, challenging new opportunity has become available with a Top Pharmaceutical Baden-Württemberg, Germany

Notice NOT-EB-18-028 from the NIH Guide for Grants and Contracts

Notice NOT-EB-18-027 from the NIH Guide for Grants and Contracts

Notice NOT-EB-18-025 from the NIH Guide for Grants and Contracts

Notice NOT-EB-18-026 from the NIH Guide for Grants and Contracts

Notice NOT-MH-19-002 from the NIH Guide for Grants and Contracts

Notice NOT-OD-19-017 from the NIH Guide for Grants and Contracts

Negotiable: Paramount Recruitment: Technical Innovator - Bioinformatics Cambridge I have a great opportunity available to work with one of the leading organisations within bioinformati Cambridge, England

Notice NOT-DE-18-024 from the NIH Guide for Grants and Contracts

Notice NOT-DK-19-002 from the NIH Guide for Grants and Contracts

Notice NOT-DK-19-001 from the NIH Guide for Grants and Contracts

Emphasis in social sciences, public health, bioinformatics, computer science, or related field preferred....
From University of Wisconsin–Madison - Thu, 11 Oct 2018 18:57:33 GMT - View all Madison, WI jobs

Funding Opportunity RFA-FD-19-001 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development through the characterization of the natural history of rare diseases/conditions with unmet needs. Through the support of efficient and innovative natural history studies, FDA expects to address critical knowledge gaps, to remove major barrier(s) to progress in the field, to exert a significant and broad impact on a specific rare disease or multiple rare diseases with similar pathophysiology, and to inform current or future product development including the design of clinical trial(s) and to ultimately inform the development of medical products that meet patient needs.

Funding Opportunity RFA-AA-19-004 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for specialized Alcohol Research Centers using the P50 mechanism. The overall purpose of the NIAAA Alcohol Research Center program is to provide leadership in conducting and fostering interdisciplinary, collaborative research on a wide variety of topics relevant to the Institutes mission. These topics include, but are not limited to: the nature, etiology, genetics, diagnosis, treatment, and prevention of alcohol use disorders and their biomedical, psychosocial, and economic consequences across the lifespan. Centers also are regional or national resources that contribute to the development of new research methods, technologies and approaches that sustain innovative goal-directed research

Funding Opportunity RFA-DK-18-018 from the NIH Guide for Grants and Contracts. This FOA invites applications for Clinical Centers to carefully characterize the normal course of glycemia over the entire duration of pregnancy and understand the evolution of dysglycemia when it occurs. Clinical Centers will recruit and study pregnant women starting in the first trimester and continuing at least through delivery. A separate FOA (RFA-DK-18-019) will solicit a Biostatistics Research Center. Each Clinical Center applicant will propose a study design and provide detailed information about recruitment capacity. All awardees will form a cooperative research consortium in conjunction with NIDDK to design and implement a uniform protocol. Information obtained from this study is expected to lead to improved approaches for screening for GDM, and inform the timing and approach for future clinical trials to decrease adverse perinatal outcomes and long-term sequelae of dysglycemia during pregnancy in both the mother and offspring.

Funding Opportunity RFA-DK-18-019 from the NIH Guide for Grants and Contracts. This FOA invites applications for a Biostatistics Research Center to participate in a clinical consortium to carefully characterize the course of glycemia over the entire duration of pregnancy and understand the evolution of dysglycemia when it occurs. A separate FOA (RFA-DK-18-018) invites Clinical Centers to recruit and study pregnant women starting in the first trimester, and continuing at least through delivery. All awardees will form a cooperative research consortium in conjunction with NIDDK to design and implement a uniform protocol. Information obtained from this study is expected to lead to improved approaches for screening for GDM, and inform the timing and approach for future clinical trials to decrease adverse perinatal outcomes and long-term sequelae of dysglycemia during pregnancy in both the mother and offspring.

It is expected that the incumbent will master specific technical skills commensurate with modern microbiology that include cultivation and bioinformatic...
From DuPont - Wed, 10 Oct 2018 20:57:09 GMT - View all Madison, WI jobs

Funding Opportunity RFA-AI-18-045 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to develop biomarkers/bioassays, techniques and/or devices for use in the civilian population that are rapid, reliable, inexpensive and easy-to-use. This FOA will support approaches addressing one or more of the following research gaps: 1. Distinguish between the worried well and the exposed population, 2. Determine the radiation dose in the affected group, 3. Predict the acute and delayed radiation injuries to major organs/physiological systems by discovering biomarkers that can be used for triage and treatment decisions in the event of a large scale radiological incident.